1. mponesto
2. dddimensions
3. thegoldbug
4. ladygodiva9293
5. 49bjoe
1.dddimensions 04/25/2018
New Oncology Clinical Collaboration between Nektar and Takeda to Evaluate Combination of NKTR-214, a CD122-biased Agonist, and TAK-659, a Dual SYK and FLT-3 Inhibitor, in Liquid and Solid Tumors
2.davsdu94 02/14/2018
up 11.02%.
3.thegoldbug 02/26/2018
Another biotech winner so far in 2018, up 50% so far.
4.49bjoe 04/11/2018
Company has initiated dosing patients in the Phase 1/2 REVEAL clinical study evaluating the efficacy and saf…
5.renysion 06/04/2018
Nektar Therapeutics (NKTR): Should You Cut and Run?
6.davsdu94 06/04/2018
Upgraded to BUY on my list ;) {Image}
7.einstein4539 06/07/2018
Nektar Therapeutics (NKTR): One Bull Is Still 'Impressed' Despite This Stock's Worst Plunge on Record
8.nomercjr 05/14/2018
Canaccord Genuity sets PT at $94
9.ladygodiva9293 06/04/2018
H.C. Wainwright Slashes Price Target on Nektar Therapeutics (NKTR), Says 'Optimism Has Been Eroded'
10.dddimensions 04/24/2018
Nektar Therapeutics enters into a new clinical collaboration
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW